JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB1903

Anti-Alpha-synuclein 抗体 [4D6] - BSA and Azide free

Anti-Alpha-synuclein antibody [4D6] - BSA and Azide free

4

(4 Reviews)

|

(99 Publications)

Anti-Alpha-synuclein antibody [4D6] - BSA and Azide free (ab1903) is a mouse monoclonal antibody provided in a PBS only buffer for easy conjugation detecting Alpha-synuclein in Western Blot, IHC-P. Suitable for Human.

- BSA, sodium azide, and glycerol-free for easy conjugation
- Over 70 publications
- Trusted since 2004

別名を表示する

NACP, PARK1, SNCA, Alpha-synuclein, Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor

2 Images
Western blot - Anti-Alpha-synuclein antibody [4D6] - BSA and Azide free (AB1903)
  • WB

Unknown

Western blot - Anti-Alpha-synuclein antibody [4D6] - BSA and Azide free (AB1903)

All lanes:

Western blot - Anti-Alpha-synuclein antibody [4D6] - BSA and Azide free (ab1903) at 5 µg/mL

Lane 1:

A549 (Human lung adenocarcinoma epithelial cell line) Whole Cell Lysate at 10 µg

Lane 2:

SK N BE (Human neuroblastoma) Whole Cell Lysate at 10 µg

Lane 3:

SK N SH (Human neuroblastoma) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 14 kDa

Observed band size: 16 kDa,18 kDa,80 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Alpha-synuclein antibody [4D6] - BSA and Azide free (AB1903)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Alpha-synuclein antibody [4D6] - BSA and Azide free (AB1903)

IHC-P using ab1903 showing lewy bodies in a human substantia nigra neuron(x400)

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

4D6

アイソタイプ

IgG1

キャリアフリー

Yes

交差種

Human

アプリケーション

WB, IHC-P

applications

免疫原

Recombinant Full Length Protein corresponding to Human SNCA.

P37840

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/1000", "IHCP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/100 - 1/10000", "WB-species-notes": "<p></p>", "ICC-species-checked": "notRecommended", "ICC-species-dilution-info": "", "ICC-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "1 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>" } } }

製品の詳細

What is this antibody validated in?
Anti-Alpha-synuclein antibody [4D6] - BSA and Azide free (ab1903) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of Alpha-synuclein?
Anti-Alpha-synuclein [4D6] - BSA and Azide free (ab1903) specifically detects a band for Alpha-synuclein (UniProt: P37840) at a molecular weight of 16kDa.

Trusted by the scientific community
Anti-Alpha-synuclein [4D6] - BSA and Azide free (ab1903) was first used in a scientific publication in 2004 and has been cited over 70 times in peer-reviewed journals.

Reviewed by scientists
Anti-Alpha-synuclein [4D6] - BSA and Azide free (ab1903) has over 5 independent reviews from customers.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
精製に関する特記事項
Ammonium sulfate precipitated and dialyzed tissue culture supernatant.
バッファー組成
Constituents: PBS
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Alpha-synuclein often referred to by alternate names such as SNCA is a protein of around 14 kDa mass. It mainly expresses in the brain particularly in presynaptic nerve terminals. This protein functions mechanically by stabilizing synaptic vesicles and maintaining synaptic function. It exists both in soluble monomer forms and as aggregates in protein filaments. Antibodies like 4D6 and EP1536Y target monomer forms of protein for more detailed studies.
Biological function summary

The alpha-synuclein protein plays critical roles in neuronal activity. It contributes to neurotransmitter release regulation by acting in the formation and plasticity of the presynaptic neuronal network. Alpha-synuclein doesn't usually form parts of large protein complexes but it may associate transiently with membranes and vesicular structures. The protein's monomer form has also been observed in alpha lines and related neuronal processes operating alongside various cellular functions.

Pathways

Synaptic vesicle trafficking and dopamine neurotransmitter release are significant areas involving the alpha-synuclein protein. In these pathways alpha-synuclein interacts with other proteins like synaptophysin and protein monomer monomerizations are intrinsic to these processes. Altered function or aggregation of alpha-synuclein disrupts these pathways influencing broader neurological functions.

Alterations or accumulations of alpha-synuclein are strongly linked to Parkinson's disease and Lewy body dementia. In these conditions alpha-synuclein forms abnormal protein filaments known as Lewy bodies within neurons. These formations disrupt cellular processes and neuron health. Synucleinopathies such as these show connections with proteins like parkin and DJ-1 which also have key roles in these neurodegenerative diseases.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

The protein expressed by the SNCA gene is involved in various synaptic activities, including the regulation of synaptic vesicle trafficking and neurotransmitter release. As a monomer, it enhances synaptic vesicle exocytosis through vesicle priming, fusion, and dilation of exocytotic fusion pores. Mechanistically, it increases local Ca(2+) release, which is crucial for ATP-induced exocytosis. In its multimeric membrane-bound form, SNCA acts as a molecular chaperone, assisting in the folding of synaptic fusion components known as SNAREs at the presynaptic plasma membrane, in conjunction with cysteine string protein-alpha/DNAJC5, a function that is vital for maintaining normal SNARE-complex assembly during aging. Additionally, SNCA plays a role in dopamine neurotransmission regulation by associating with the dopamine transporter (DAT1) and modulating its activity. This supplementary information is collated from multiple sources and compiled automatically.
See full target information SNCA

文献 (99)

Recent publications for all applications. Explore the full list and refine your search

Translational neurodegeneration 14:26 PubMed40420149

2025

Development of human targeted extracellular vesicles loaded with shRNA minicircles to prevent parkinsonian pathology.

Applications

Unspecified application

Species

Unspecified reactive species

Maria Izco,Carlos Sola,Martin Schleef,Marco Schmeer,María de Toro,Guglielmo Verona,Estefania Carlos,Alejandro Reinares-Sebastian,Sandra Colina,Maria Eugenia Marzo-Sola,Josune Garcia-Sanmartin,Joaquín Fernández-Irigoyen,Enrique Santamaría,Rodolfo Mugica-Vidal,Javier Blesa,Lydia Alvarez-Erviti

Journal of neurology 272:299 PubMed40156621

2025

PRNP E146G mutation inherited prion disease: distinctive clinical, pathological and fluid biomarker features.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas Coysh,Zane Jaunmuktane,Laszlo L P Hosszu,Nour Majbour,Fuquan Zhang,Tracy Campbell,Lee Darwent,Marcelo Barria Matus,Edgar Chan,Leah Holm-Mercer,Tze How Mok,Jonathan D F Wadsworth,Jan Bieschke,Kannan Nithi,Sebastian Brandner,Colin Smith,Margaret Esiri,John Collinge,Simon Mead

NPJ Parkinson's disease 11:47 PubMed40089519

2025

Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson's disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation.

Applications

Unspecified application

Species

Unspecified reactive species

Chunyan Mu,Kaiquan Shao,Mingyu Su,Yurong Guo,Yuxiang Qiu,Ruiao Sun,Sihan Sun,Yaoyu Sun,Chenkai Liu,Wei Wang,Xiaoling Qin,Chuanxi Tang

Cell biology and toxicology 41:34 PubMed39847159

2025

Manganese exposure induces parkinsonism-like symptoms by Serpina3n-TFEB-v/p-ATPase signaling mediated lysosomal dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

Huihui Hong,Sicheng Liu,Ting Yang,Jinxian Lin,Kun Luo,Yudong Xu,Ting Li,Yu Xi,Lingling Yang,Yuan-Qiang Lu,Wei Yuan,Zhou Zhou

CNS neuroscience & therapeutics 30:e70088 PubMed39444113

2024

Microglial Melatonin Receptor 1 Degrades Pathological Alpha-Synuclein Through Activating LC3-Associated Phagocytosis In Vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao-Yu Yao,Bing-Er Cao,Jun-Yi Liu,Qian-Kun Lv,Jia-Rui Zhang,Xiao-Yu Cheng,Cheng-Jie Mao,Quan-Hong Ma,Fen Wang,Chun-Feng Liu

NPJ Parkinson's disease 10:194 PubMed39443520

2024

CRBN modulates synuclein fibrillation via degradation of DNAJB1 in mouse model of Parkinson disease.

Applications

Unspecified application

Species

Unspecified reactive species

Uroos Akber,Jun-Hyung Jung,Heewoong Yoon,Jiwon Seo,Chul-Seung Park

International journal of medical sciences 21:1472-1490 PubMed38903914

2024

Retinal ganglion cell type-specific expression of synuclein family members revealed by scRNA-sequencing.

Applications

Unspecified application

Species

Unspecified reactive species

Qingwen Yang,Lin Liu,Fang He,Wenna Zhao,Zhongqun Chen,Xiaotian Wu,Bilin Rao,Xin Lin,Fangyuan Mao,Jia Qu,Jun Zhang

Neuropathology and applied neurobiology 50:e12973 PubMed38558379

2024

Argyrophilic grain disease and co-pathologies in an older patient with a rapidly progressive neuropsychiatric syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Camilla N Clark,Norman Poole,Jeremy D Isaacs,Andrew D MacKinnon,Philip Rich,Leslie R Bridges,Zane Jaunmuktane,Elizabeth Caruana Galizia

Scientific reports 14:6239 PubMed38486089

2024

Solubility of α-synuclein species in the L62 mouse model of synucleinopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Karima Schwab,Mandy Magbagbeolu,Franz Theuring,Charles R Harrington,Claude M Wischik,Gernot Riedel

Journal of pineal research 76:e12948 PubMed38488331

2024

Melatonin MT1 receptors regulate the Sirt1/Nrf2/Ho-1/Gpx4 pathway to prevent α-synuclein-induced ferroptosis in Parkinson's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Qian-Kun Lv,Kang-Xin Tao,Xiao-Yu Yao,Meng-Zhu Pang,Bing-Er Cao,Chun-Feng Liu,Fen Wang
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com